eSense-Lab is a pharmatech company that is re-engineering the chemical composition of plants, starting with cannabis, in order to reformulate them for commercial applications.
The company applies cutting-edge technologies and disruptive techniques to reverse engineer rare or lucrative plants, deconstructing the chemical profiles and using alternate natural products to then re-engineer and create the virtual plant.
The result is a line of plant-based products with commercial and medicinal applications, viable for multiple markets and mass consumer consumption.
eSense-Lab is an Israel-based life sciences research and development company listed on the ASX (ESE).
Cumulative Funding Raised Over Time ($)
Employees Over Time
eSense-Lab Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jul 23, 2020
www.proactiveinvestors.com.au
eSense-Lab in trading halt ahead of news on research agreement with Israeli Ministry of Health
undefined
Jul 15, 2020
www.proactiveinvestors.com.au
eSense-Lab achieves key milestones that validate commercialisation model for terpenes
undefined
Jul 7, 2020
stockhead.com.au
eSense-Lab signs deal to start on its US sales journey - Stockhead
#Partners
Jun 18, 2020
www.businessnewsasia.com
eSense-Lab Inks Deal with Wise Winery for Terpenes-Infused Sanitisers
#Partners #Customers
Jun 15, 2020
finfeed.com
eSense-Lab strikes JV to develop and a sell new range of terpene products